they've done another study on Hydroxychloroquine in France and again appears to be beneficial at reducing viral load and hospital stay to a median of 5 days. Still only on 80 patients but says clinical improvement in all but two which, although not a large-scale trial seems promising.
they've done another study on Hydroxychloroquine in France and again appears to be beneficial at reducing viral load and hospital stay to a median of 5 days. Still only on 80 patients but says clinical improvement in all but two which, although not a large-scale trial seems promising.
https://www.mediterranee-infection.com/wp-content/uploads/2020/03/COVID-IHU-2-1.pdf?fbclid=IwAR2yKLqUxKnmjx6WsmXaao0z2wgNj3TUdW_vZ9l1CBYGNCsCE3CwczILxm0